Back
Open Access

Successful treatment of MR and TR patients​ with differentiated transcatheter technologies.

Session: Transcatheter options for the management of HF patients with MR or TR: the new ESC-HF and ESC/EACTS VHD guidelines
Topic: Chronic Heart Failure
Speaker: Professor R. von Bardeleben (Mainz, DE)
Sponsored by Edwards Lifesciences
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Professor Ralph Stephan von Bardeleben

University Medical Center of Mainz, Mainz (Germany)
72 presentations
6 followers

4 more presentations in this session

Session opening​.

Speaker: Professor J. Bax (Leiden, NL)

Access
Video
Like
Thumbnail

Supporting HF treatment through transcatheter valve therapy​.

Speaker: Professor M. Boehm (Homburg, DE)

Access
Video
Like
Thumbnail

ESC-HF guidelines for management of MR and TR: the update and its clinical implications.

Speaker: Professor J. Bax (Leiden, NL) Professor R. von Bardeleben (Mainz, DE) Professor M. Boehm (Homburg, DE)

Access
Video
Like
Thumbnail

Session evaluation and key learnings​.

Speaker: Professor J. Bax (Leiden, NL)

Access
Video
Like
Thumbnail

Access the full session

Transcatheter options for the management of HF patients with MR or TR: the new ESC-HF and ESC/EACTS VHD guidelines

Speakers: Professor R. von Bardeleben, Professor J. Bax, Professor M. Boehm, Professor J. Bax, Professor R. von Bardeleben...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources